6 ',6 '-Dichloro-3,3 ''-etheno-3,4,3 '',4 ''-tetrahydro-2H-1,3-benzoxazine-2-spiro-2 '-(2 lambda(5),4 lambda(5),6 lambda(5)-cyclotriphosphazene)-4 '-spiro-2 ''-2H-1,3-benzoxazine

TERCAN, B; Hokelek, TUNCER; BILGE, S; NATSAGDORJ, A; DEMIRIZ, S; KILIC, Z

doi:10.1107/s160053680400858x

6 ',6 '-Dichloro-3,3 ''-etheno-3,4,3 '',4 ''-tetrahydro-2H-1,3-benzoxazine-2-spiro-2 '-(2 lambda(5),4 lambda(5),6 lambda(5)-cyclotriphosphazene)-4 '-spiro-2 ''-2H-1,3-benzoxazine

TERCAN B., Hokelek T., BILGE S., NATSAGDORJ A., DEMIRIZ S., KILIC Z.

ACTA CRYSTALLOGRAPHICA SECTION E-CRYSTALLOGRAPHIC COMMUNICATIONS, vol.60, 2004 (SCI-Expanded, ESCI, Scopus)

Publication Type: Article / Article
Volume: 60
Publication Date: 2004
Doi Number: 10.1107/s160053680400858x
Journal Name: ACTA CRYSTALLOGRAPHICA SECTION E-CRYSTALLOGRAPHIC COMMUNICATIONS
Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Emerging Sources Citation Index (ESCI), Scopus
Hacettepe University Affiliated: Yes

Abstract

The title compound, C16H16Cl2N5O2P3, a cyclotriphosphazene, has a spiro-ansa-spiro architecture in which the bicyclic system is in the sofa conformation. Two P atoms and one N atom are capable of representing stereogenic centres.